EPPIC Global Presents: Role of AI/ML in Transforming and Accelerating the Drug Discovery Process October 17, 2020 Event twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii. READ MORE
